Table 1 Clinical characteristics (n = 63)
From: Testing the effects of gentle vibrotactile stimulation on symptom relief in fibromyalgia
Age, years, mean (SD) | 53.7 (8.1) |
|---|---|
Sex, females, n (%) | 63 (100) |
Height, cm, mean (SD) | 161 (6) |
Weight, kg, mean (SD) | 69.2 (13.6) |
Hand-dominance, n (%) right-handers | 56 (89) |
Education level, years, mean (SD) | 14.1 (3.9) |
Illness duration, mean (SD), years since diagnosis | 7.7 (5.8) |
Fibromyalgia Impact Questionnaire*, mean (SD) | 63.6 (15.1) |
General perception of health**, mean (SD) | 33.1 (17.6) |
Hospital Anxiety and Depression Scale (HADS) | |
Anxiety, mean (SD) | 11.2 (4.1) |
Depression, mean (SD) | 9.8 (4.4) |
Stable medication regime | |
NSAIDs, n (%) | 29 (46) |
Opioids (tramadol), n (%) | 24 (38) |
Paracetamol, n (%) | 34 (54) |
Gabapentin, n (%) | 25 (40) |
Antidepressants | |
SSRI, n (%) | 18 (29) |
SNRI, n (%) | 20 (32) |
Others, n (%) | 14 (22) |
Anxiolytics/hypnotics (benzodiazepines), n (%) | 42 (67) |